Get more information on Neuroscience Market - Request Free Sample Report
The Neuroscience Market size was estimated at USD 45.07 billion in 2023 and is expected to reach USD 70.75 billion by 2031 at a CAGR of 5.80% during the forecast period of 2024-2031.
Neuroscience is the scientific study of the nervous system, including its structure, function, and illnesses. It includes a number of sub-disciplines that work together to solve the mysteries of the brain and its intricate workings. The discovery and marketing of tools, technologies, and therapies that aid in the understanding, diagnosis, and treatment of neurological illnesses is part of the neuroscience market.
DRIVERS
A growing emphasis on personalized medicine and precision neuroscience
The growing emphasis on customized medicine and precision neuroscience presents enormous market growth potential. For market participants, the discovery of innovative medicines and interventions for neurodegenerative illnesses represents a viable avenue. Because of improved healthcare infrastructure and increased healthcare expenditure, emerging regions in Asia Pacific and Latin America provide untapped prospects for expansion.
RESTRAIN
Expensive costs
The high expenses of neuroscience research, particularly the creation of novel therapies and medications, provide a significant barrier to market expansion.
Ethical concerns about specific neuroscience studies and interventions may limit the scope of research and development initiatives.
Strict regulatory standards for neurological product and therapy approval might cause market entrance and commercialization delays.
OPPORTUNITY
The increased emphasis on personalized medicine and precision neuroscience creates enormous market growth opportunities.
For market participants, the development of novel drugs and therapies for neurodegenerative diseases is a promising avenue.
As healthcare infrastructure improves and healthcare spending increases, emerging nations in Asia Pacific and Latin America provide unexplored opportunities for growth.
CHALLENGES
Brain illness classification and simulation
There were no major revisions to the carrying amounts of recognized assets and liabilities in fiscal year 2022 due to the war in Ukraine. Siemens Healthineers has no manufacturing facilities in Ukraine or Russia. Further escalation of the war, possibly additional sanctions, or exchange rate developments for the different local currencies could have a detrimental influence on the sales and service units' commercial activities. The associated dangers are continuously monitored.
By Component
Instruments
Consumables
Software & Services
In 2022, the instruments segment is expected to held the highest market share of 64.7% during the forecast period due to the introduction of new instrument technologies for diagnosing and treating neurological illnesses. Koninklijke Philips N.V. released the Philips CT 3500, an AI-powered CT scanner, in May 2023 to handle regular radiology and high-volume screening programs. This technology can provide radiologists with the high-quality images they need to make accurate diagnosis.
By Technology
n 2022, the brain Imaging segment is expected to dominate the market growth of 25.3% during the forecast period. forecast period. This can be ascribed to the increased use of brain imaging techniques, such as MRI, EEG, and CT scans, to identify neurological illnesses in hospitals, diagnostic centers, and ambulatory surgery centers (ASCs). According to NHS England and the NHS Improvement Report 2022, around 67,227 persons were referred for brain MRI scans in March 2022 by physicians for cancer diagnosis.
By End User
In 2022, the diagnostic laboratories segment is expected to dominate the market growth of 42.2% during the forecast period owing to the broad application breadth of neurological equipment in diagnostic laboratories, as well as greater public awareness of the benefits of early disease detection. Each year, more than 90,000 people are diagnosed with Parkinson's disease, according to the Parkinson's Foundation. CT scans, MRIs, electroencephalograms (EEG), electromyograms (EMG), and other neurological devices are commonly utilized at diagnostic centers for diagnosis.
North America held a significant market share of 31.6% in 2022. This is due to the region's substantial presence of enterprises engaged in designing, manufacturing, and commercializing technologies used to diagnose and treat neurological patients. CERENOVUS, for example, developed an enhanced balloon guide catheter, EMBOGUARD, in February 2022, to be used in endovascular treatments, particularly in patients with acute ischemic stroke. During the projection period, the Asia Pacific region is expected to grow the fastest.
Asia-Pacific is witness to expand fastest CAGR rate of during the forecast due to increased investments in healthcare logistic infrastructure, as well as increased healthcare spending, which is fueling the rise of the neuroscience business. The Chinese government announced the "China Brain Project (CBP)" in September 2022, with an initial investment of USD 746 million, with the goal of focusing on topics such as the neural basis of cognitive functions, brain-inspired computing, and detecting and treating brain illnesses. Such public-sector initiatives are expected to increase R&D in neurology, ultimately driving market expansion.
Need any customization research on Neuroscience Market - Enquiry Now
The major key players are Carl Zeiss AG, Danaher Corporation, GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips N.V., Canon Inc., B. Braun SE, Medtronic, Stryker, Boston Scientific Corporation, ABBOTT, Terumo Corporation, and Others.
In May 2023, Dr. Thomas Oxley and Nicholas Opie of Australia invented a human-brain-computer interface technology that remotely transmits data from the patient's brain to operate external digital equipment, allowing severely crippled individuals to communicate using their thoughts.
In May 2023, the US Food and Drug Administration (FDA) approved Neurophet AQUA, an artificial intelligence (AI) software, to improve the assessment of brain atrophy on MRI. This launch will assist clinicians in giving patients with the best treatment options while also improving brain monitoring.
| Report Attributes | Details |
| Market Size in 2023 | US$ 45.07 Bn |
| Market Size by 2031 | US$ 70.75 Bn |
| CAGR | CAGR of 5.80% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Component (Instruments, Consumables, Software & Services) • By Technology (Brain Imaging, Neuro-Microscopy, Stereotaxic Surgeries, Neuro-Proteomic Analysis, Neuro-Cellular Manipulation, Others) • By End User (Hospitals, Diagnostic Laboratories, Research and Academic Institute) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Carl Zeiss AG, Danaher Corporation, GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips N.V., Canon Inc., B. Braun SE, Medtronic, Stryker, Boston Scientific Corporation, ABBOTT, Terumo Corporation |
| Key Drivers | • A growing emphasis on personalized medicine and precision neuroscience |
| Market Opportunities | • The increased emphasis on personalized medicine and precision neuroscience creates enormous market growth opportunities. • For market participants, the development of novel drugs and therapies for neurodegenerative diseases is a promising avenue. |
Ans: The growth rate of neuroscience market is expected to grow USD 65.8 billion by 2030.
Ans: Neuroscience market size was valued at USD 42.6 billion in 2022.
Ans: Ethical considerations surrounding certain neuroscience studies and interventions may limit the scope of research and development activities
Ans: Neuroscience market is anticipated to expand by 5.6% from 2023 to 2030.
Ans: North America segment is expected to held the highest market share in 2022.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Neuroscience Market Segmentation, By Component
8.1 Instruments
8.2 Consumables
8.3 Software & Services
9. Neuroscience Market Segmentation, By Technology
9.1 Brain Imaging
9.2 Neuro-Microscopy
9.3 Stereotaxic Surgeries
9.4 Neuro-Proteomic Analysis
9.5 Neuro-Cellular Manipulation
9.6 Others
10. Neuroscience Market Segmentation, By End User
10.1 Hospitals
10.2 Diagnostic laboratories
10.3 Research and Academic Institute Diabetes
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Neuroscience Market by Country
11.2.2North America Neuroscience Market by Component
11.2.3 North America Neuroscience Market by Technology
11.2.4 North America Neuroscience Market by End User
11.2.5 USA
11.2.5.1 USA Neuroscience Market by Component
11.2.5.2 USA Neuroscience Market by Technology
11.2.5.3 USA Neuroscience Market by End User
11.2.6 Canada
11.2.6.1 Canada Neuroscience Market by Component
11.2.6.2 Canada Neuroscience Market by Technology
11.2.6.3 Canada Neuroscience Market by End User
11.2.7 Mexico
11.2.7.1 Mexico Neuroscience Market by Component
11.2.7.2 Mexico Neuroscience Market by Technology
11.2.7.3 Mexico Neuroscience Market by End User
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Neuroscience Market by Country
11.3.1.2 Eastern Europe Neuroscience Market by Component
11.3.1.3 Eastern Europe Neuroscience Market by Technology
11.3.1.4 Eastern Europe Neuroscience Market by End User
11.3.1.5 Poland
11.3.1.5.1 Poland Neuroscience Market by Component
11.3.1.5.2 Poland Neuroscience Market by Technology
11.3.1.5.3 Poland Neuroscience Market by End User
11.3.1.6 Romania
11.3.1.6.1 Romania Neuroscience Market by Component
11.3.1.6.2 Romania Neuroscience Market by Technology
11.3.1.6.4 Romania Neuroscience Market by End User
11.3.1.7 Turkey
11.3.1.7.1 Turkey Neuroscience Market by Component
11.3.1.7.2 Turkey Neuroscience Market by Technology
11.3.1.7.3 Turkey Neuroscience Market by End User
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Neuroscience Market by Component
11.3.1.8.2 Rest of Eastern Europe Neuroscience Market by Technology
11.3.1.8.3 Rest of Eastern Europe Neuroscience Market by End User
11.3.2 Western Europe
11.3.2.1 Western Europe Neuroscience Market by Component
11.3.2.2 Western Europe Neuroscience Market by Technology
11.3.2.3 Western Europe Neuroscience Market by End User
11.3.2.4 Germany
11.3.2.4.1 Germany Neuroscience Market by Component
11.3.2.4.2 Germany Neuroscience Market by Technology
11.3.2.4.3 Germany Neuroscience Market by End User
11.3.2.5 France
11.3.2.5.1 France Neuroscience Market by Component
11.3.2.5.2 France Neuroscience Market by Technology
11.3.2.5.3 France Neuroscience Market by End User
11.3.2.6 UK
11.3.2.6.1 UK Neuroscience Market by Component
11.3.2.6.2 UK Neuroscience Market by Technology
11.3.2.6.3 UK Neuroscience Market by End User
11.3.2.7 Italy
11.3.2.7.1 Italy Neuroscience Market by Component
11.3.2.7.2 Italy Neuroscience Market by Technology
11.3.2.7.3 Italy Neuroscience Market by End User
11.3.2.8 Spain
11.3.2.8.1 Spain Neuroscience Market by Component
11.3.2.8.2 Spain Neuroscience Market by Technology
11.3.2.8.3 Spain Neuroscience Market by End User
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Neuroscience Market by Component
11.3.2.9.2 Netherlands Neuroscience Market by Technology
11.3.2.9.3 Netherlands Neuroscience Market by End User
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Neuroscience Market by Component
11.3.2.10.2 Switzerland Neuroscience Market by Technology
11.3.2.10.3 Switzerland Neuroscience Market by End User
11.3.2.11. Austria
11.3.2.11.1 Austria Neuroscience Market by Component
11.3.2.11.2 Austria Neuroscience Market by Technology
11.3.2.11.3 Austria Neuroscience Market by End User
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Neuroscience Market by Component
11.3.2.12.2 Rest of Western Europe Neuroscience Market by Technology
11.3.2.12.3 Rest of Western Europe Neuroscience Market by End User
11.4 Asia-Pacific
11.4.1 Asia-Pacific Neuroscience Market by Country
11.4.2 Asia-Pacific Neuroscience Market by Component
11.4.3 Asia-Pacific Neuroscience Market by Technology
11.4.4 Asia-Pacific Neuroscience Market by End User
11.4.5 China
11.4.5.1 China Neuroscience Market by Component
11.4.5.2 China Neuroscience Market by Technology
11.4.5.3 China Neuroscience Market by End User
11.4.6 India
11.4.6.1 India Neuroscience Market by Component
11.4.6.2 India Neuroscience Market by Technology
11.4.6.3 India Neuroscience Market by End User
11.4.7 Japan
11.4.7.1 Japan Neuroscience Market by Component
11.4.7.2 Japan Neuroscience Market by Technology
11.4.7.3 Japan Neuroscience Market by End User
11.4.8 South Korea
11.4.8.1 South Korea Neuroscience Market by Component
11.4.8.2 South Korea Neuroscience Market by Technology
11.4.8.3 South Korea Neuroscience Market by End User
11.4.9 Vietnam
11.4.9.1 Vietnam Neuroscience Market by Component
11.4.9.2 Vietnam Neuroscience Market by Technology
11.4.9.3 Vietnam Neuroscience Market by End User
11.4.10 Singapore
11.4.10.1 Singapore Neuroscience Market by Component
11.4.10.2 Singapore Neuroscience Market by Technology
11.4.10.3 Singapore Neuroscience Market by End User
11.4.11 Australia
11.4.11.1 Australia Neuroscience Market by Component
11.4.11.2 Australia Neuroscience Market by Technology
11.4.11.3 Australia Neuroscience Market by End User
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Neuroscience Market by Component
11.4.12.2 Rest of Asia-Pacific Neuroscience Market by Technology
11.4.12.3 Rest of Asia-Pacific Neuroscience Market by End User
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Neuroscience Market by Country
11.5.1.2 Middle East Neuroscience Market by Component
11.5.1.3 Middle East Neuroscience Market by Technology
11.5.1.4 Middle East Neuroscience Market by End User
11.5.1.5 UAE
11.5.1.5.1 UAE Neuroscience Market by Component
11.5.1.5.2 UAE Neuroscience Market by Technology
11.5.1.5.3 UAE Neuroscience Market by End User
11.5.1.6 Egypt
11.5.1.6.1 Egypt Neuroscience Market by Component
11.5.1.6.2 Egypt Neuroscience Market by Technology
11.5.1.6.3 Egypt Neuroscience Market by End User
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Neuroscience Market by Component
11.5.1.7.2 Saudi Arabia Neuroscience Market by Technology
11.5.1.7.3 Saudi Arabia Neuroscience Market by End User
11.5.1.8 Qatar
11.5.1.8.1 Qatar Neuroscience Market by Component
11.5.1.8.2 Qatar Neuroscience Market by Technology
11.5.1.8.3 Qatar Neuroscience Market by End User
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Neuroscience Market by Component
11.5.1.9.2 Rest of Middle East Neuroscience Market by Technology
11.5.1.9.3 Rest of Middle East Neuroscience Market by End User
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by Country
11.5.2.2 Africa Neuroscience Market by Component
11.5.2.3 Africa Neuroscience Market by Technology
11.5.2.4 Africa Neuroscience Market by End User
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Neuroscience Market by Component
11.5.2.5.2 Nigeria Neuroscience Market by Technology
11.5.2.5.3 Nigeria Neuroscience Market by End User
11.5.2.6 South Africa
11.5.2.6.1 South Africa Neuroscience Market by Component
11.5.2.6.2 South Africa Neuroscience Market by Technology
11.5.2.6.3 South Africa Neuroscience Market by End User
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Neuroscience Market by Component
11.5.2.7.2 Rest of Africa Neuroscience Market by Technology
11.5.2.7.3 Rest of Africa Neuroscience Market by End User
11.6 Latin America
11.6.1 Latin America Neuroscience Market by Country
11.6.2 Latin America Neuroscience Market by Component
11.6.3 Latin America Neuroscience Market by Technology
11.6.4 Latin America Neuroscience Market by End User
11.6.5 Brazil
11.6.5.1 Brazil Neuroscience Market by Component
11.6.5.2 Brazil Neuroscience Market by Technology
11.6.5.3 Brazil Neuroscience Market by End User
11.6.6 Argentina
11.6.6.1 Argentina Neuroscience Market by Component
11.6.6.2 Argentina Neuroscience Market by Technology
11.6.6.3 Argentina Neuroscience Market by End User
11.6.7 Colombia
11.6.7.1 Colombia Neuroscience Market by Component
11.6.7.2 Colombia Neuroscience Market by Technology
11.6.7.3 Colombia Neuroscience Market by End User
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Neuroscience Market by Component
11.6.8.2 Rest of Latin America Neuroscience Market by Technology
11.6.8.3 Rest of Latin America Neuroscience Market by End User
12 Company Profile
12.1 Carl Zeiss AG
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Product/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Danaher Corporation
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 GE Healthcare
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Siemens Healthcare Private Limited
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Koninklijke Philips N.V.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Canon Inc.
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 B. Braun SE
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Medtronic
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Stryker
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Boston Scientific Corporation
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 ABBOTT
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Product/Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.12 Terumo Corporation
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Product/Services Offered
12.12.4 SWOT Analysis
12.12.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Component
Instruments
Consumables
Software & Services
By Technology
Brain Imaging
Neuro-Microscopy
Stereotaxic Surgeries
Neuro-Proteomic Analysis
Neuro-Cellular Manipulation
Others
By End User
Hospitals
Diagnostic laboratories
Research and Academic Institute
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Osteoporosis Treatment Market Size was valued at USD 13.28 billion in 2023, and is expected to reach USD 19.39 billion by 2032, and grow at a CAGR of 4.3% over the forecast period 2024-2032.
The Bilirubin Blood Test Market Size was valued at USD 1.18 billion in 2023, and is expected to reach USD 2.11 billion by 2032, and grow at a CAGR of 6.7% over the forecast period 2024-2032.
The Echocardiography Market was estimated at US$ 2.01 billion in 2023 and is expected to reach US$ 3.54 billion by 2031 and is anticipated to increase at a CAGR of 7.21% predicted for the forecast period of 2024-2031.
The Real-Time PCR (qPCR) Market Size was valued at USD 5.7 billion in 2023 and expected to reach USD 8.4 billion by 2031, and grow at a CAGR of 5.1% over the forecast period 2024-2031.
The Blockchain Technology in Healthcare Market Size was valued at $3.3 Bn in 2023 & will reach $214.44 Bn by 2031, & grow at a CAGR of 68.5% by 2024-2031.
The Angioplasty Balloon Market size was estimated at USD 3.05 billion in 2023 and will hit USD 4.18 billion by 2031 growing at a CAGR of 4.01% by 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
